In a metastatic HER2-overexpressing BC patient, an adoptive transfer of autologous HER2-specific cytotoxic T cells has been shown to lead to accumulated T cells in the bone marrow along with a loss of bone marrow-residing disseminated tumor cells (75). The gene discussed is ERBB2; the disease is breast cancer.